MedLink International, Inc. (MLKNA)
- Previous Close
0.0000 - Open
0.0000 - Bid --
- Ask --
- Day's Range
0.0000 - 0.0000 - 52 Week Range
0.0000 - 0.0001 - Volume
1,100 - Avg. Volume
0 - Market Cap (intraday)
4,760 - Beta (5Y Monthly) -46.65
- PE Ratio (TTM)
0.01 - EPS (TTM)
0.0100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
MedLink International, Inc. engages in selling, implementing, and supporting software solutions that provide physician practices, laboratories, and other healthcare organizations access to clinical, administrative, and financial data. The company offers MedLink iSuite EHR that automates physician activities, such as prescribing, dictating, ordering lab tests and viewing results, documenting clinical encounters, and capturing charges, among others; and MedLink IX (Information eXchange), an enterprise connectivity solution that links providers and healthcare services to achieve interoperability deployed in commercial and hospital laboratories. It also provides MedLink Lab, a Web browser based lab ordering and results portal hosted on the company's virtual cloud platform; and MedLink Connect, which allows laboratory services to utilize MedLink IX to deliver laboratory results to multiple HIS and EMR, as well as Health Information networks. MedLink International sells its products through direct sales force. The company is based in Hauppauge, New York.
--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: MLKNA
View MorePerformance Overview: MLKNA
Trailing total returns as of 4/29/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MLKNA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MLKNA
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
3.38%
Return on Assets (ttm)
8.00%
Return on Equity (ttm)
9.37%
Revenue (ttm)
6M
Net Income Avi to Common (ttm)
202.68k
Diluted EPS (ttm)
0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
657.29k
Total Debt/Equity (mrq)
60.13%
Levered Free Cash Flow (ttm)
782.8k